Who is sponsoring NCT05874609?

NCT05874609 is sponsored by Peking Union Medical College Hospital.

What drugs are being tested in NCT05874609?

Interventions in NCT05874609: Teaching with VR spine simulator, Traditional didactic teaching.

What condition does NCT05874609 study?

NCT05874609 studies Neuraxial Ultrasonography.

Is NCT05874609 still recruiting?

NCT05874609 is currently status unknown. Last updated 25 May 2023.

Last reviewed 2023-05-25 · How we verify

NCT05874609

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Teaching Neuraxial Ultrasonography With a Virtual Reality Simulator of Spine

Status unknown NA Last updated 25 May 2023

What this trial tests

NA trial testing Teaching with VR spine simulator in Neuraxial Ultrasonography in 46 participants. Status unknown.

Timeline

15 June 2023

Primary endpoint
30 June 2023

30 June 2023

Quick facts

Lead sponsor	Peking Union Medical College Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	46
Start date	15 June 2023
Primary completion	30 June 2023
Estimated completion	30 June 2023

Drugs / interventions tested

Teaching with VR spine simulator
Traditional didactic teaching

Conditions studied

Neuraxial Ultrasonography — all drugs for Neuraxial Ultrasonography →

Sponsor

Peking Union Medical College Hospital

Who can join

Eligibility, any sex, with Neuraxial Ultrasonography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

As one of the most extensively practiced regional block, neuraxial anesthesia is the basic skill for anesthesiologist to acquire. Recently, virtual reality (VR) has been proposed as a new simulation training method to enhance medical education. The aim of our study is to evaluate the practical skills of ultrasound scan and the satisfaction of students who undergo training using VR versus traditional didactic lecture.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Peking Union Medical College Hospital trials

Trials by the same sponsor.

NCT07466251 — PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke · Phase 4 · not yet recruiting
NCT06743321 — Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients · NA · not yet recruiting
NCT07590336 — 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma · Phase 1, PHASE2 · not yet recruiting
NCT07515976 — Mapping of Genomic Structural Variations in Major Birth Defects · not yet recruiting
NCT07386756 — Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05874609 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College Hospital
Last refreshed: 25 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05874609.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing